Beyond Rogaine: Why KilgourMD Is Taking a Different Approach to Women’s Hair Thinning

Beyond Rogaine: Why KilgourMD Is Taking a Different Approach to Women’s Hair Thinning

Half of women over 50 will experience visible hair thinning – yet the most common treatments, including minoxidil, weren’t designed around the biology of aging women’s hair. Discover why KilgourMD focuses on the scalp environment to support healthier-looking hair.

52%

of postmenopausal women experience noticeable hair thinning — yet it remains one of the most underrecognized and undertreated conditions in women’s health.

Source: Frontiers in Pharmacology, 2025

The problem: treatments that don’t address women’s needs

When minoxidil was approved by the FDA in 1988, the research behind it was overwhelmingly male. The drug, which was originally a blood pressure medication, was repurposed after male patients reported unexpected hair growth. While a women’s formulation came later, the dose is lower, yet the side effects are worse.

The side effect problem

Minoxidil was built for men’s biology

Studies show that women using minoxidil face scalp irritation, unwanted facial hair growth, and cardiovascular concerns at higher rates than male users — partly because female hormonal profiles interact with the compound differently. Long-term adherence among women is consistently poor for exactly this reason.

The three real causes of hair loss in women after 40

Women in their 40s, 50s, and beyond, three interconnected forces are usually at work simultaneously. Any treatment that addresses only one will underperform.

Cause 01

Hormonal disruption

Declining estrogen lets DHT shrink follicles — the primary driver of pattern thinning after menopause.

Cause 02

Environmental damage

UV, pollution, and free radicals degrade the scalp barrier, triggering inflammation that shortens the growth phase.

Cause 03

Biological scalp aging

The same aging that affects facial skin reduces follicle stem cell activity and thins the dermal layer.

Most treatments address, at best, one of these:

  • Minoxidil (Rogaine) increases blood flow. It doesn’t address DHT or oxidative damage.
  • Supplements can reduce DHT via saw palmetto, but they don’t protect the scalp’s surface or reverse aging-related follicle decline. 

Other topical hair products (like thickening masks or shampoo) target the hair shaft – a dead keratin fiber. They make it look shinier, feel thicker, and sit better. But they don’t touch the follicles, scalp dermis, or stem cells that determine whether new hairs grow at all.

For every male patient I saw for hair loss, I was seeing four to five women. I was amazed at how little this group had been thought about and how disappointed my patients were by existing treatments.

— Dr. James Kilgour, MD · Founder, KilgourMD · Stanford Dermatologist

The missing piece: your scalp is aging, too

When scalp skin ages – through hormonal depletion, UV oxidative stress, and simple biology – follicles shrink, their growth cycles shorten, and hairs that do emerge are finer, shorter-lived, and increasingly sparse. Washing your hair with a “thickening” shampoo does nothing to reverse this. Neither does taking high amounts of biotin.

This is the foundation behind KilgourMD’s approach. By targeting the aging scalp with a science-backed formula designed around addressing the main causes for women, KilgourMD takes a different approach to supporting stronger, healthier-looking hair from the root.

The skincare parallel

Think about what your facial skincare routine actually does — it prevents environmental damage, supports collagen, regulates sebum, and stimulates cell turnover. Your scalp needs exactly the same attention. The difference is that nobody told you this until now.

What sets KilgourMD’s serum apart 

The most effective approach to scalp health mirrors what decades of clinical dermatology have established for facial skin: prevent the damage first, then treat what has already occurred.

“I spent two years trying everything — Nutrafol, minoxidil, every prescription my dermatologist offered. The side effects were exhausting. Three months in with KilgourMD, my ponytail is noticeably thicker and I have baby hairs along my hairline for the first time since my early 40s. I genuinely didn’t think anything would work at this point.”

SL
Sarah L., 54 KilgourMD customer · Verified purchaser

KilgourMD’s system works in two steps – a Prevention Serum that acts like an antioxidant “SPF” for the scalp, neutralizing oxidative stress and blocking DHT before damage sets in; and a Treatment Serum that stimulates follicle stem cells, activating growth in follicles that have already begun to miniaturize. Applied like a skincare serum directly on the scalp (no rinsing required!), the system integrates naturally into your routine.

Treatment KilgourMD Minoxidil
Targets scalp aging Yes No
Blocks DHT Yes No
Antioxidant protection Yes No
No known side effects Yes Documented
Designed for women Yes Adapted from men’s
Dermatologist developed Stanford MD ~ FDA approved drug
Prevention and treatment Dual system Treatment only
If you stop treatment Safe to stop anytime
(Not a drug)
Triggers “dread shed”
(Lifelong drug)

The clinical numbers behind KilgourMD’s solution

64.7%

Hair recovery rate in clinical trials vs. minoxidil’s 25.5%

200%

Greater follicle growth stimulation vs. untreated controls

30%

Reduction in visible hair fall within two months of consistent use

These results come from KilgourMD’s own clinical program, with independent third-party testing. In peer-reviewed clinical trials, this formula outperformed 5% minoxidil (the active ingredient in Rogaine, one of the most widely used hair loss treatments available) by improving hair density and reducing shedding. 

The studies measured real-world shedding markers, including hair loss during brushing and wash days – often the first signs women notice worsening. By week six, 95% of users saw a noticeable decrease in hair fall.* The 2025 clinical trial reported no serious side effects – a meaningful contrast to conventional treatments, where side-effect burden is a primary reason women stop.

Final Thoughts

Hair loss in women after 40 is a scalp problem. It starts with DHT acting on an aging, oxidatively-stressed follicle environment, and it requires a solution that addresses that environment directly, not one that arrived via a men’s clinical trial or a vitamin capsule.

KilgourMD was built from the simple observation that millions of women were being failed by a category that had barely noticed them. Science catches up when someone decides to look. If you’re ready to take a targeted approach to thinning hair and support healthier growth from the scalp up, KilgourMD is worth trying.

Start Treating Your Scalp Like It’s Part Of Your Skincare Routine

50,000+ women have switched to this dermatologist developed, scalp first hair system made for female biology. No side effects, visible results in 60 days, and your money back if it’s not for you.

Shop The System